Crossmark

Identification of Active Compounds of Hippobroma Longiflora Extract as Anticancer: Network Pharmacology, Molecular Docking, Molecular Dynamics Simulation, and Experimental Validation

Crossref DOI link: https://doi.org/10.1007/s12247-025-10209-y

Published Online: 2026-01-14

Published Print: 2026-04

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Burhan, Asril

Setiyono, Agus

Astuti, Rika Indri

Umar, Abdul Halim

Ratnadewi, Diah
Funding

Funding for this research was provided by:

Ministry of Education, Culture, Research and Technology (Kemendikbudristek) through the Doctoral Dissertation Research Scheme (No. 027/E5/PG.02.00. PL/2024 and 22180/IT3.D10/PT.01.03.P/B/2024)

Ministry of Education, Culture, Research and Technology (Kemendikbudristek) through the Doctoral Dissertation Research Scheme (No. 027/E5/PG.02.00. PL/2024 and 22180/IT3.D10/PT.01.03.P/B/2024)

Ministry of Education, Culture, Research and Technology (Kemendikbudristek) through the Doctoral Dissertation Research Scheme (No. 027/E5/PG.02.00. PL/2024 and 22180/IT3.D10/PT.01.03.P/B/2024)

Ministry of Education, Culture, Research and Technology (Kemendikbudristek) through the Doctoral Dissertation Research Scheme (No. 027/E5/PG.02.00. PL/2024 and 22180/IT3.D10/PT.01.03.P/B/2024)

Ministry of Education, Culture, Research and Technology (Kemendikbudristek) through the Doctoral Dissertation Research Scheme (No. 027/E5/PG.02.00. PL/2024 and 22180/IT3.D10/PT.01.03.P/B/2024)
License Information

Text and Data Mining valid from 2026-01-14

Version of Record valid from 2026-01-14
More Information

Article History

Received: 25 July 2025

Accepted: 8 October 2025

First Online: 14 January 2026

Declarations

:

: All authors provided informed consent.

: The authors declare no competing interests.

Document is current

Any future updates will be listed below